Literature DB >> 7472511

The behavior of APO-SUS rats in animal models with construct validity for schizophrenia.

B A Ellenbroek1, M A Geyer, A R Cools.   

Abstract

Schizophrenic patients are known to suffer from a number of information processing disturbances, including deficits in both prepulse inhibition of startle and latent inhibition. Since these behavioral phenomena can also be observed in animals, they represent an ideal starting point for developing animal models having construct validity for specific deficits observed in schizophrenia. The principal question is how to induce a condition in animals most similar to the schizophrenic deficit. In the present study, we have selected rats on the basis of their response to an open filed or to the dopaminergic agonist apomorphine, and evaluated their prepulse inhibition and latent inhibition. We used three different selection procedures (open field selection for novelty response, gnawing cage selection for apomorphine response, and pharmacogenetic selection for apomorphine response). The results show that, irrespective of the selection procedure used, rats with a high response to novelty or apomorphine susceptible (collectively called APO-SUS rats) show diminished prepulse inhibition of the acoustic startle response as compared to rats with a low response to novelty or apomorphine unsusceptible (collectively called APO-UNSUS rats). This difference was apparent only at low prepulse intensities. Moreover, these APO-SUS rats show diminished latent inhibition in a conditioned taste aversion paradigm as compared to APO-UNSUS rats. Given the fact that the pharmacogenetically bred APO-SUS rats show several central nervous, endocrinological, and immunological similarities to schizophrenic patients, they are hypothesised to represent an interesting nonpharmacological animal model for schizophrenia-prone patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472511      PMCID: PMC6578060     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  18 in total

1.  Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Authors:  Lisa H Conti; Jane E Sutherland; Carey M Muhlhauser
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

2.  Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment.

Authors:  T Dejaegere; L Serneels; M K Schäfer; J Van Biervliet; K Horré; C Depboylu; D Alvarez-Fischer; A Herreman; M Willem; C Haass; G U Höglinger; R D'Hooge; B De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

3.  Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.

Authors:  Ignasi Oliveras; Ana Sánchez-González; Daniel Sampedro-Viana; Maria Antonietta Piludu; Cristóbal Río-Alamos; Osvaldo Giorgi; Maria G Corda; Susana Aznar; Javier González-Maeso; Cristina Gerbolés; Gloria Blázquez; Toni Cañete; Adolf Tobeña; Alberto Fernández-Teruel
Journal:  Psychopharmacology (Berl)       Date:  2017-02-02       Impact factor: 4.530

4.  Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.

Authors:  Martine C J van der Elst; Yvette S Wunderink; Bart A Ellenbroek; Alexander R Cools
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

5.  Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.

Authors:  N R Swerdlow; Z A Martinez; F M Hanlon; A Platten; M Farid; P Auerbach; D L Braff; M A Geyer
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 6.  Brain-corticosteroid hormone dialogue: slow and persistent.

Authors:  E R de Kloet; N Y Rots; A R Cools
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

7.  Correlation between cataleptic freezing and prepulse inhibition of the startle reflex in rats.

Authors:  N N Barykina; T A Alekhina; V F Chugui; O I Petrenko; N K Popova; V G Kolpakov
Journal:  Neurosci Behav Physiol       Date:  2004-05

Review 8.  Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.

Authors:  Michael F Green; Pamela D Butler; Yue Chen; Mark A Geyer; Steven Silverstein; Jonathan K Wynn; Jong H Yoon; Vance Zemon
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

9.  A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating.

Authors:  Neal R Swerdlow; Michelle Breier; Adrienne B Mora; David Ko; Jody M Shoemaker
Journal:  Pharmacol Biochem Behav       Date:  2007-09-04       Impact factor: 3.533

10.  Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.

Authors:  Michel M M Verheij; Jesse V Veenvliet; Tom Groot Kormelink; Maaike Steenhof; Alexander R Cools
Journal:  Psychopharmacology (Berl)       Date:  2009-05-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.